ArticleInternational journal of molecular sciences2022

Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism.

Pei-Wei Shueng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.